- Home
- BDL vs RANI Comparison
BDL vs RANI Comparison
Compare BDL & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- RANI
- Stock Information
- Founded
- BDL 1959
- RANI 2012
- Country
- BDL United States
- RANI United States
- Employees
- BDL N/A
- RANI N/A
- Industry
- BDL Restaurants
- RANI Medicinal Chemicals and Botanical Products
- Sector
- BDL Consumer Discretionary
- RANI Health Care
- Exchange
- BDL Nasdaq
- RANI Nasdaq
- Market Cap
- BDL 48.0M
- RANI 41.6M
- IPO Year
- BDL N/A
- RANI 2021
- Fundamental
- Price
- BDL $24.90
- RANI $1.31
- Analyst Decision
- BDL
- RANI Strong Buy
- Analyst Count
- BDL 0
- RANI 5
- Target Price
- BDL N/A
- RANI $11.80
- AVG Volume (30 Days)
- BDL 3.5K
- RANI 420.9K
- Earning Date
- BDL 02-11-2025
- RANI 11-14-2024
- Dividend Yield
- BDL 2.01%
- RANI N/A
- EPS Growth
- BDL N/A
- RANI N/A
- EPS
- BDL 1.81
- RANI N/A
- Revenue
- BDL $188,100,000.00
- RANI N/A
- Revenue This Year
- BDL N/A
- RANI N/A
- Revenue Next Year
- BDL N/A
- RANI N/A
- P/E Ratio
- BDL $13.79
- RANI N/A
- Revenue Growth
- BDL 7.96
- RANI N/A
- 52 Week Low
- BDL $23.94
- RANI $1.24
- 52 Week High
- BDL $29.72
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- BDL 50.23
- RANI 35.89
- Support Level
- BDL $24.30
- RANI $1.24
- Resistance Level
- BDL $25.44
- RANI $1.61
- Average True Range (ATR)
- BDL 0.66
- RANI 0.11
- MACD
- BDL -0.00
- RANI 0.02
- Stochastic Oscillator
- BDL 55.56
- RANI 18.92
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.